References
- Weve H. On diathermy in ophthalmic practice. Trans Ophthalmol Soc UK 1939; 59:43–80.
- Stallard HB. Radiotherapy for malignant melanoma of the choroid. Br J Ophthalmol 1966; 50:147–55.
- Augsburger JJ, Gamel JW, Sardi VF, Greenberg RA, Shields JA, Brady LW. Enucleation vs. cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol 1986;104:655–61.
- Char DH, Castro JR, Kroll SM, Irvine AR, Quivey JM, Stone RD. Five-year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol 1990;108:209–14.
- Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, Albert DM. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 1990;97:769–77.
- Foulds WS, Damato BE, Burton RL. Local resection versus enucleation in the management of choroidal melanoma. Eye 1987;1:676–9.
- Meyer-Schwickerath G, Vogel M. Treatment of malignant melanomas of the choroid by photocoagula-tion. Trans Ophthalmol Soc UK 1977; 97:416–20.
- Fine SL. No one knows the preferred management for choroidal melanoma. Am J Ophthalmol 1996;122:106–8.
- Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition: The Collaborative Ocular Melanoma Study. Controlled Clin Trials 1993;14:362–91.
- Ware JE, Snow ICK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993.
- Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473–83.
- McHorney CA, Ware JE, Lu JFR, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40–66.
- Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston: The Health Institute, New England Medical Center, 1994;8:23,28.
- Lee PP, Whitcup SM, Hays RD, Spritzer K, Javitt J. The relationship between visual acuity and functioning and well-being among diabetics. Qual Life Res 1995;4:319–23.
- Musch DC, Farjo AA, Meyer RF, Waldo MN, Janz NK. Assessment of health-related quality of life after corneal transplantation. Am J Ophthalmol 1997;124:1–8.
- Parrish RK. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma. Trans Am Ophthalmol Soc 1996;94:919–1028.
- Lee PP, Spritzer K, Hays RD. The impact of blurred vision on functioning and well-being. Ophthalmology 1997;104:390–6.
- Thompson JR, Sparrow JM, Gibson JM, Rosenthal AR. Cataract and survival in an elderly nondiabetic population. Arch Ophthalmol 1993;m:675–9.
- Applegate WB, Miller ST, Elam JT, Freeman JO, Gettlefinger TC. Impact of cataract surgery with lens implantation on vision and physical function in elderly patients. JAMA 1987; 257(8):1064–6.
- Klein R, Klein BEK, Linton KLP, DeMets DL. The Beaver Dam Eye Study: Visual Acuity. Ophthalmol-ogy 1991;98:1310–5.
- Tielsch JM, Sommer A, Witt K, Katz J, Royall RM, the Baltimore Eye Survey Research Group. Blindness and visual impairment in an American urban population. Arch Ophthalmol 1990;108:286–90.
- McHorney CA, Ware HE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31: 247–63.
- Gliklich RE, Hilinski JM. Longitudinal sensitivity of generic and specific health measures in chronic sinusitis. Quality of Life Res 1995;4:27–32.
- Guyatt GH, Jaeschke R, Feeny DH, Patrick DL. Measurements in clinical trials: Choosing the right approach. In: Spilker B, editor. Quality of Life and Pharmacoeco-nomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven Publishers, 1996:41–8.